-
Doctors have a new option for suicidal patients. It's a fast-acting nasal spray containing a version of the anesthetic ketamine.
-
A Stanford research team finds that ketamine's ability to quickly relieve depression may depend on activating the brain's opioid system. The finding raises new questions about the drug's safety.
-
More and more doctors are offering ketamine, an anesthetic and club drug, to severely depressed patients who haven't responded to other treatments.